Speciality Medicines Board Meeting Date
Speciality Medicines Limited has scheduled a board meeting on November 12, 2026. The board will consider and approve unaudited standalone financial results for the half-year ended September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Speciality Medicines Limited has scheduled a board meeting on November 12, 2026. The board will consider and approve unaudited standalone financial results for the half-year ended September 30, 2026.
Speciality Medicines Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31.
Speciality Medicines Limited conducted its 5th Annual General Meeting on September 28, 2026. Shareholders considered the adoption of FY26 audited financial statements and the re-appointment of Director Sumit Goyani.